nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—osteoarthritis	0.872	1	CbGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.0181	0.142	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGES—osteoarthritis	0.0117	0.0921	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—osteoarthritis	0.00808	0.0633	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—FRZB—osteoarthritis	0.00681	0.0533	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00653	0.0512	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00556	0.0436	CbGpPWpGaD
Phenylbutazone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00441	0.0346	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—osteoarthritis	0.0043	0.0337	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00361	0.0283	CbGpPWpGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.00355	0.0278	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.00295	0.0231	CbGpPWpGaD
Phenylbutazone—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00287	0.0225	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.0023	0.0181	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00201	0.0157	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.00193	0.0151	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—GSTO1—osteoarthritis	0.00171	0.0134	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—BMP2—osteoarthritis	0.00162	0.0127	CbGpPWpGaD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00159	0.0125	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00128	0.01	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.00127	0.00998	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.00126	0.00989	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.00118	0.00921	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.00117	0.00919	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.00109	0.00854	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00106	0.00827	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—SMAD3—osteoarthritis	0.00102	0.00798	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.00101	0.00792	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.000983	0.00771	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000933	0.00731	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000933	0.00731	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—LEP—osteoarthritis	0.00087	0.00682	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.000854	0.00669	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000828	0.00649	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—osteoarthritis	0.000822	0.00645	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000721	0.00565	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IGF1—osteoarthritis	0.000719	0.00564	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.000708	0.00555	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000657	0.00515	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FMOD—osteoarthritis	0.000609	0.00477	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.000592	0.00464	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000579	0.00454	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000576	0.00452	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IHH—osteoarthritis	0.000543	0.00425	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.000526	0.00412	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000521	0.00409	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—FMOD—osteoarthritis	0.00051	0.004	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000466	0.00365	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.000465	0.00365	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000458	0.00359	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TGFB1—osteoarthritis	0.000431	0.00338	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGES—osteoarthritis	0.000416	0.00326	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFBI—osteoarthritis	0.000405	0.00317	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—osteoarthritis	0.000403	0.00316	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000394	0.00309	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.000374	0.00293	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000369	0.00289	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—GSTO1—osteoarthritis	0.00035	0.00274	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—BGN—osteoarthritis	0.000339	0.00265	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—osteoarthritis	0.000325	0.00255	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000303	0.00238	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000297	0.00232	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GSTO1—osteoarthritis	0.000293	0.00229	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000287	0.00225	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—BGN—osteoarthritis	0.000284	0.00222	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000281	0.0022	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000277	0.00217	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000273	0.00214	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.00025	0.00196	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000233	0.00183	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000229	0.0018	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000228	0.00178	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000226	0.00177	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000211	0.00165	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000207	0.00162	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000185	0.00145	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000183	0.00143	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000182	0.00143	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00018	0.00141	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000169	0.00133	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SMAD3—osteoarthritis	0.000166	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FMOD—osteoarthritis	0.000157	0.00123	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	0.000153	0.0012	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000151	0.00118	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000149	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FMOD—osteoarthritis	0.000149	0.00116	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	0.000146	0.00115	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	0.000138	0.00108	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000136	0.00107	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	0.000134	0.00105	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IHH—osteoarthritis	0.000132	0.00104	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000129	0.00101	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGES—osteoarthritis	0.000128	0.001	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FMOD—osteoarthritis	0.000124	0.000975	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	0.000114	0.000891	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	0.000108	0.000849	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	0.000106	0.000832	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTGES—osteoarthritis	0.000101	0.000795	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFBI—osteoarthritis	9.87e-05	0.000774	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—osteoarthritis	9.73e-05	0.000763	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GSTO1—osteoarthritis	9e-05	0.000705	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BGN—osteoarthritis	8.72e-05	0.000683	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	8.57e-05	0.000671	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GSTO1—osteoarthritis	8.53e-05	0.000669	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BGN—osteoarthritis	8.26e-05	0.000648	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FMOD—osteoarthritis	8.24e-05	0.000646	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—osteoarthritis	8.15e-05	0.000639	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.73e-05	0.000606	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	7.22e-05	0.000566	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GSTO1—osteoarthritis	7.14e-05	0.00056	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—osteoarthritis	7.04e-05	0.000552	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BGN—osteoarthritis	6.92e-05	0.000542	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGES—osteoarthritis	6.72e-05	0.000526	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.63e-05	0.000441	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FMOD—osteoarthritis	5.43e-05	0.000426	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—osteoarthritis	5.3e-05	0.000416	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GSTO1—osteoarthritis	4.73e-05	0.000371	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BGN—osteoarthritis	4.58e-05	0.000359	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGES—osteoarthritis	4.43e-05	0.000347	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SMAD3—osteoarthritis	4.06e-05	0.000318	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GSTO1—osteoarthritis	3.12e-05	0.000245	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BGN—osteoarthritis	3.02e-05	0.000237	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.96e-05	0.000232	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—osteoarthritis	2.51e-05	0.000196	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—osteoarthritis	1.72e-05	0.000135	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—osteoarthritis	1.32e-05	0.000103	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—osteoarthritis	1.29e-05	0.000101	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—osteoarthritis	8.69e-06	6.81e-05	CbGpPWpGaD
